Novel pan-cancer T cell exhaustion signature forecasts immunotherapy response and unveils BCAP31 in macrophages as a therapeutic target in neuroblastoma.

By employing 113 predictive ML approaches and a LOOCV system, we refined a highly significant model and benchmarked it against existing in immunotherapy related signatures ( Figure 9A ).

also in 132,142 other papers